Target intelligence / Profile preview

Viral lipid membrane

Molecular classification
Other (lipid bilayer), Not a protein, receptor, enzyme, or nucleic acid
01

Overview

The **viral lipid membrane** (or viral envelope) is a lipid bilayer derived from the plasma membrane or organelle membranes of the host cell during viral replication and budding[1][4]. It is a structural component of enveloped viruses, surrounding the viral capsid and genome, and embedded with viral glycoproteins necessary for host cell entry[1][4]. The lipid composition is typically enriched for certain lipids (such as sphingolipids and cholesterol) and exhibits domains that influence the mechanical properties, flexibility, curvature, and infectivity of the virus[1][4][7]. Alterations in this membrane can disrupt viral entry or egress, making it a conceptual but unconventional therapeutic target[7]. Lipid-targeting antiviral strategies remain largely experimental, with most approved antivirals focusing instead on viral proteins. **Note:** The viral lipid membrane is a structural feature—not a receptor, enzyme, or canonical macromolecular drug target. While it is targeted by some experimental therapies and physical interventions (e.g., lipidomimetics and detergents), it does not fit the standard definitions for drug targets such as "receptor," "enzyme," or "transporter." Therefore, **is_incorrect=true** for queries expecting a conventional molecular target.

Other names
Viral envelope lipid bilayerViral membraneEnveloped virus membrane
02

Mechanism of action

Disruption of viral membrane order/structure to impair fusion and infectivity [7] Detergent-mediated solubilization or destabilization of viral envelope [7]

03

Biological functions

Encloses and protects viral genomeFacilitates virus entry by membrane fusionSupports assembly and release of viral particlesOrganizes viral surface proteins for host cell attachment and entry
04

Disease associations

Infection (general role in all enveloped viruses)Other (enables viral infectivity and pathogenesis)
05

Safety considerations

Potential non-selectivity, risk of damaging host cell membranes [7]Toxicity noted with detergent-based interventions [7]
06

Interacting drugs

Lipidomimetic compounds (e.g., J391B, J582C, IBS70; experimental) [7]

2 more in the full profile.

Beyond the preview

Go deeper on Viral lipid membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral lipid membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call